People Innovation Excellence

Reynetha D.S. Rawendra, S.TP, M.P, M.Sc, Ph.D

Reynetha D.S. Rawendra, S.TP, M.P, M.Sc, Ph.D
Subject Content Coordinator – Food Science
Department of Food Technology
Bina Nusantara University
h-index= 3

2012 – July, 2015 : Ph.D. Food Science
National Pingtung University of Science and Technology, Pingtung-Taiwan.
Dissertation: Identification of Novel and Potential Therapeutic Agents from Natural Products in the Treatment of Hypertension and Acute Promyelocytic Leukemia.

2012 – 2010 : M.Sc. M.P. Double Degree. Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung-Taiwan and Agro-industrial Biotechnology, Brawijaya University, Malang-Indonesia.
Thesis: Screening of active peptides with antihypertensive activity from biological sources by LCMS/MS

2008 – 2004 : B.Sc. Food Science, Bogor Agricultural University, Bogor-Indonesia
2003 – 2000 : St. Alberts Senior High School, Malang, East Java, Indonesia
2000 – 1997 : Randwick Girls Sydney Technology High School , Sydney-New South Wales, Australia
1997 – 1993 : Kensington Public School, Sydney-New South Wales, Australia

September 2017 – now: Subject Content Coordinator – Food Science, Department of Food Technology, Bina Nusantara University
October 2016 – August 2017 : Lecturer – Faculty of Veterinary Medicine, University of Brawijaya, Malang.
Taught subjects: biochemistry, molecular biology, molecular biology techniques and analysis, genetic engineering, biotechnology.

April 2016- October 2016: Postdoctoral Fellow – Institute of Biomedical Science, Academia Sinica, Taipei-Taiwan.
Research: Protein-protein interaction study and molecular mechanism analysis underlying atherosclerosis using proteomic approach

2014 – 2015: Clinical Research Associate – iSRed Pharma & Biotech Research Co., Ltd., Taichung-Taiwan
Description : Monitoring clinical trials throughout its duration, visiting trial sites on a regular basis, verify data entered on case report forms (CRFs), writing visit reports, discussing results with medical statistician, assessing suitability of facilities to be used as the clinical trial sites, managing regulatory authority applications and approvals that oversee the research and marketing of new and existing drugs.

2010 – 2008 : Quality Control and Assurance Supervisor – Bernardi Meat Processing and Frozen Foods, Surabaya-Indonesia.
Description : Design, coordinate, and direct a quality control program that meets with company and government’s established standards. Manage audits by third-party inspectors.
Achievement : Brought the company to obtain ISO 22000-An international standard and certification for food safety management system.

May 2017 : Microfluidics & Biosensor Technology Workshop, Penang-Malaysia
Feb 2017 : Swiss-Indonesia Vaccine Formulation Symposium and Workshop, Surabaya-Indonesia
2011 : Risk Management Certification Training, Surabaya- Indonesia
2010 : Food safety management systems, Jakarta-Indonesia
2010 : Business management training for young, high potential managers, Jakarta-Indonesia
2009 : Hazard analysis and critical control points (HACCP) certification training, Indonesia National Agency of Drug and Food Control, Bogor-Indonesia

2012 Outstanding Paper Award on 2012 Symposium on Natural Products Chemistry for Graduate Students, Pingtung-Taiwan
2011 M.S., Agroindustrial Biotechnology Cum Laude, Brawijaya University, Malang-Indonesia

CERTIFICATE: Dec 2012 TOEFL ITP Score Total: 600
2010-2012 Unggulan Scholarship, Indonesian Directorate General of Higher Education (Ministry of National Education), Masters Degree
2012-2015 Outstanding International Student Scholarship, National Pingtung University of Science and Technology, Doctorate Degree

2010-2016 : Proteomic, protein digestion and purification, 2D gel electrophoresis, HPLC, protein identification by LCMS/MS, immunoprecipitation of complexes for identification by mass-spectrometry, antihypertension in-vitro assays, in-vivo assays using spontaneously hypertensive rats model, western blotting, computer assisted molecular docking, protein structure –activity relationship studies.
2012-2015 : Mammalian cell culture, signal transduction pathway in inflammation and cancer, in-vivo leukemia study in mice, sub-acute and acute toxicity study of compounds and drugs in BALB/c mice.
2014-2015 : Human clinical trials, bioavailability and bioequivalent study

1. Rawendra, R. D. S., Aisha, Chang, C. I., Aulanni’am, Chen, H. H., Huang, T. C., & Hsu, J. L. (2013). A Novel Angiotensin Converting Enzyme Inhibitory Peptide Derived from Proteolytic Digest of Chinese Soft-shelled Turtle Egg White Proteins.
Journal of Proteomics, 94, 359-369. doi: DOI 10.1016/j.jprot.2013.10.006. Accepted October 6th , 2013
Q1 Biochemistry
Q1 Biophysics

2. Rawendra, R. D. S., Aisha, Chen, S. H., Chang, C. I., Shih, W. L., Liao, M. H, Huang, T. C., & Hsu, J. L. (2014). Isolation and Characterization of a Novel Angiotensin-Converting Enzyme-Inhibitory Tripeptide from Enzymatic Hydrolysis of Soft-Shelled Turtle (Pelodiscus sinensis) Egg White: In Vitro, In Vivo, and In Silico Study. Journal of Agricultural and Food Chemistry, 62(50), 12178-12185. doi: DOI 10.1021/Jf504734g. Accepted November 17th , 2014
Q1 Agricultural and Biological Sciences (miscellaneous)
Q1 Chemistry (miscellaneous)

3. Su, P. S., Doerksen, R. J., Chen, S. H., Sung, W. C., Juan, C. C., Rawendra, R. D. S., Chen, C. R., Li, J. W., Aisha, Huang, T. C., Liao, M. H., Chang, C. I., Hsu, J. L. (2015). Screening and Profiling Stilbene-type Natural Products with Angiotensin-
Converting Enzyme Inhibitory Activity from Ampelopsis brevipedunculate var. hancei (Planch.) Rehder. Journal of Pharmaceutical and Biomedical Analysis, 108c: 70-77. doi: 10.1016/j.jpba.2015.01.053
Q1 Analytical Science
Q1 Pharmaceutical Science

4. Rawendra, R. D. S., Lin, P. Y, Chang, C. D., Hsu, J. L., Huang, Shih,W. L., Huang, T. C., Liao,M. H, Hsu, J. L., Huang, T. C., Shih, W. L. (2015). Potentiation of Acute Promyelocytic Leukemia Cells Differentiation and Prevention of Leukemia Development
in Mice by by Oleanolic Acid. Journal of Anticancer Research. 2015 Dec;35(12):6583-90. Accepted October 15th , 2015
Q2 Oncology

Last updated :

Periksa Browser Anda

Check Your Browser

Situs ini tidak lagi mendukung penggunaan browser dengan teknologi tertinggal.

Apabila Anda melihat pesan ini, berarti Anda masih menggunakan browser Internet Explorer seri 8 / 7 / 6 / ...

Sebagai informasi, browser yang anda gunakan ini tidaklah aman dan tidak dapat menampilkan teknologi CSS terakhir yang dapat membuat sebuah situs tampil lebih baik. Bahkan Microsoft sebagai pembuatnya, telah merekomendasikan agar menggunakan browser yang lebih modern.

Untuk tampilan yang lebih baik, gunakan salah satu browser berikut. Download dan Install, seluruhnya gratis untuk digunakan.

We're Moving Forward.

This Site Is No Longer Supporting Out-of Date Browser.

If you are viewing this message, it means that you are currently using Internet Explorer 8 / 7 / 6 / below to access this site. FYI, it is unsafe and unable to render the latest CSS improvements. Even Microsoft, its creator, wants you to install more modern browser.

Best viewed with one of these browser instead. It is totally free.

  1. Google Chrome
  2. Mozilla Firefox
  3. Opera
  4. Internet Explorer 9